OxySure Therapeutics, Inc.: key financial figures for fiscal year 2014 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2014)
- $2.4M
- Net Income/Loss (FY2014)
- -$2.8M
- Total Assets (FY2014)
- $2.5M
- Total Equity (FY2014)
- $1.1M
- Cash Flows from Operating Activities (FY2014)
- -$1.1M
Source: OxySure Therapeutics, Inc. 10-K filing (FY2014). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
